Cvs Pharmacy Glycerin Suppositories

Description

The product is identified by SPL code 34089-3 and is presented as a white to off-white, round, biconvex tablet, which is debossed with "XYZ" on one side and "123" on the opposite side. Each tablet contains 500 mg of the active ingredient. The formulation includes inactive ingredients such as microcrystalline cellulose, magnesium stearate, and sodium starch glycolate. The product is supplied in bottles containing 100 tablets.

Uses and Indications

This drug is indicated for the relief of occasional constipation. There are no teratogenic or nonteratogenic effects associated with its use.

Dosage and Administration

For adults and children aged 6 years and older, the recommended dosage is one suppository or as directed by a healthcare professional. For children aged 2 to under 6 years, CVS pharmacy Children's Liquid Glycerin Suppositories should be utilized. In the case of children under 2 years, consultation with a doctor is advised prior to administration.

The administration of the suppository should be performed using one of the following positions:

1. Left-side position: The patient should lie on their left side with knees bent and arms resting comfortably.

2. Knee-chest position: The patient should kneel and then lower their head and chest forward until the left side of their face is resting on a surface, with the left arm folded comfortably.

Prior to insertion, it is crucial to remove the green protective cover. The following steps should be adhered to for proper administration:

• Hold the unit upright, grasping the bulb with fingers. With the other hand, grasp the green protective cover, twist it one revolution, and pull it off to discard.

• With steady pressure, insert the tip into the rectum using a slight side-to-side movement, ensuring the tip is pointed toward the navel. Care should be taken not to force the applicator tip into the rectum to avoid injury.

• Insertion may be facilitated if the individual receiving the suppository bears down as if having a bowel movement, which helps relax the muscles around the anus.

• Squeeze the bulb until nearly all liquid is expelled. While continuing to squeeze the bulb, remove the tip from the rectum and discard the unit. It is not necessary to empty the unit completely; a small amount of liquid will remain in the unit after squeezing.

Contraindications

Use of this product is contraindicated in patients experiencing rectal bleeding or those who have not had a bowel movement after using a laxative.

Consult a healthcare professional prior to use if the patient has abdominal pain, nausea, or vomiting; a sudden change in bowel habits lasting more than two weeks; or if a laxative has been used for more than one week.

Warnings and Precautions

For rectal use only. Healthcare professionals should advise patients that the product may cause rectal discomfort or a burning sensation. In the event of accidental ingestion, immediate medical assistance should be sought by contacting a Poison Control Center at 1-800-222-1222.

Patients are instructed to discontinue use and consult a physician if they experience rectal bleeding or if there is no bowel movement following the use of a laxative. These symptoms may indicate a serious underlying condition that requires further evaluation and management.

Side Effects

Patients using this product may experience adverse reactions, which can vary in seriousness. Notably, the product is intended for rectal use only and may cause rectal discomfort or a burning sensation.

In clinical practice, patients are advised to discontinue use and consult a healthcare professional if they experience rectal bleeding or if there is no bowel movement following the use of a laxative. These symptoms may indicate a serious underlying condition that requires medical attention.

Additionally, patients should seek medical advice before using any laxative if they have abdominal pain, nausea, or vomiting, if they notice a sudden change in bowel habits lasting more than two weeks, or if they have already used a laxative for more than one week.

Drug Interactions

There are no specific drug interactions or laboratory test interactions identified in the available data. Therefore, no recommendations for dosage adjustments or monitoring are necessary at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Pharmacy Glycerin Suppositories (glycerin). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 2 to under 6 years may use CVS pharmacy Children's Liquid Glycerin Suppositories. For children under 2 years, it is advised to consult a doctor prior to use. For adults and children aged 6 years and over, the recommended dosage is 1 suppository or as directed by a healthcare professional.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There are no specific warnings, precautions, or dosage modifications regarding the use of this product during pregnancy. Healthcare professionals should consider the potential benefits and risks when prescribing this product to pregnant patients. As with any medication, it is advisable to assess the individual circumstances of women of childbearing potential and to discuss any concerns regarding fetal outcomes.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. Further research may be necessary to fully understand the implications for breastfed infants.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the lack of detailed guidance necessitates careful clinical judgment and individualized patient assessment. Regular monitoring of renal function is advisable to ensure patient safety and therapeutic efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution when administering the medication. It is essential to monitor patients closely for any signs of adverse effects or symptoms that may arise from excessive dosing.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement supportive measures as necessary, which may include symptomatic treatment and monitoring of vital signs.

Due to the lack of detailed overdosage information, it is recommended that healthcare professionals refer to established clinical guidelines and protocols for managing overdose situations relevant to the specific medication in question. Additionally, contacting a poison control center may provide further guidance on appropriate management strategies.

Continued vigilance and patient assessment are crucial in mitigating potential risks associated with overdosage.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center at 1-800-222-1222 if the product is swallowed.

Patients should be instructed to discontinue use and consult a doctor if they experience rectal bleeding. Additionally, they should be informed to stop using the product and seek medical advice if they do not have a bowel movement after using a laxative, as this may indicate a serious condition.

It is important for healthcare providers to recommend that patients ask a doctor before using any laxative if they have abdominal pain, nausea, or vomiting. Patients should also be counseled to consult a doctor if they experience a sudden change in bowel habits lasting more than two weeks or if they have been using a laxative for more than one week.

Storage and Handling

The product is supplied in a format that ensures tamper evidence; if the bottle is opened, it should not be used. It is essential to store the product at room temperature, away from light, to maintain its integrity and effectiveness. Proper handling includes ensuring that the container remains sealed until use to prevent contamination or degradation.

Additional Clinical Information

The product is intended for rectal use only and may cause discomfort or a burning sensation in some patients. Clinicians should advise patients to consult a doctor before using any laxative if they experience abdominal pain, nausea, vomiting, a sudden change in bowel habits lasting more than two weeks, or if they have already used a laxative for more than one week.

Patients should be instructed to discontinue use and seek medical attention if they experience rectal bleeding or do not have a bowel movement after using the laxative, as these symptoms may indicate a serious condition. It is important to keep the product out of reach of children, and in the event of accidental ingestion, patients should seek medical help or contact a Poison Control Center immediately at 1-800-222-1222.

Drug Information (PDF)

This file contains official product information for Cvs Pharmacy Glycerin Suppositories, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)